Contract Analytical Services

Polyplus-transfection Launches Residual Test for Transfection Reagents

August 03, 2020

The company has launched a residual GMP-compliant test and dual sourcing opportunity designed to increase compliance and reduce risks for ATMP manufacture.

MilliporeSigma Invests $20 Million in New Switzerland Laboratory

August 03, 2020

The investment will allow for the expansion of analytical R&D efforts and will support the company’s reference materials business.

Predicting Extractables and Leachables from Container Stoppers

August 01, 2020

Data from migration kinetics studies can be used to develop models that predict levels of leachables and extractables at different temperatures and time points.

Keeping Aggregation Under Control

April 07, 2020

Characterizing and controlling protein aggregation is vital to ensure safety and efficacy of a biopharmaceutical product. In this interview, important aspects of protein aggregation and the tools available to address this issue are discussed.

Stability Testing: The Crucial Development Step

March 02, 2020

BioPharm International

As compounds become more complex in nature and biological ingredients are more widely used, stability testing approaches must follow suit and provide flexibility for developers.

Eurofins DiscoverX Grants Bioassay Certification to VelaLabs

February 28, 2020

Eurofins DiscoverX partners with VelaLabs to enable VelaLabs to perform highly reproducible potency lot release assays under GLP/GMP conditions.

Meeting E&L Expectations

December 02, 2019

As regulatory bodies extend the oversight of E&L testing, companies working with drug products need to make provisions on how to best comply with the evolving expectations.

De-risking Biologics Development Through Advanced Mass Spectrometry Approaches

August 01, 2019

BioPharm International

Using advanced HDX-MS and native MS techniques can improve the identification of potentially successful biologic drugs and de-risk CMC and clinical designs.

Cytel, Axio Unite for Analytical Solutions

June 13, 2019

The companies will form a biometrics organization focused on delivering analytical solutions for drug development.

Aptar Acquires Nanopharm and Gateway Analytical

June 13, 2019

The acquisitions, totaling $50 million, are expected expand Aptar Pharma’s service offerings to support complex product development.